Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Sustained Release Excipients Market Report 2018-2025 By Product (Polymers, Gelatin), Route of Administration (Oral, Transdermal) & Technology (Targeted Delivery) -

Research and Markets
Posted on: 30 Oct 18

The "Sustained Release Excipients Market Size, Share & Trends Analysis Report By Product (Polymers, Gelatin), By Route of Administration (Oral, Transdermal), By Technology (Targeted Delivery), And Segment Forecasts, 2018 - 2026" report has been added to's offering.

The global sustained release excipients market size is expected to reach USD 1.6 billion by 2026 at a 7.1% CAGR during the forecast period

Increasing focus on novel drug delivery R&D and rising adoption of extended release formulations for treatment of chronic diseases are major factors driving the market.

Use of sustained release drug formulations provides patients relief from these symptoms and helps maintain desired therapeutic drug levels in the body. In comparison to conventional drugs, sustained drug release technologies provide a wide range of benefits. Reduced dosage frequency, improved patient compliance, maintenance of constant level of drug in blood plasma, lower instances of toxicity due to overdose, and higher cost-effectiveness in the long run are some of the major advantages of using this technology.

Global rise in incidence of chronic and infectious diseases has also resulted in antibiotic resistance, which negatively affects the market for conventional dosage forms. Thus, alternative methods to manage and treat these diseases are being implemented. Use of sustained release formulations has been widely accepted among physicians in order to combat antibiotic resistance.

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Research Methodology

Chapter 3 Sustained Release Excipients Market Variables, Trends & Scope

Chapter 4 Sustained Release Excipients Market: Product Estimates & Trend Analysis

Chapter 5 Sustained Release Excipients Market: Route of Administration Estimates & Trend Analysis

Chapter 6 Sustained Release Excipients Market: Technology Estimates & Trend Analysis

Chapter 7 Sustained Release Excipients Market: Regional Estimates & Trend Analysis, by Product, Route of Administration, and Technology

Chapter 8 Competitive Landscape: Sustained Release Drugs

Chapter 9 Competitive Landscape: Sustained Release Technology

Chapter 10 Product Pipeline Analysis

  • Depomed, Inc.
  • Coating Place, Inc.
  • Corium International, Inc.
  • Orbis Biosciences, Inc.
  • Capsugel
  • Aradigm Corporation
  • Alkermes plc

For more information about this report visit

View source version on

Business Wire

Last updated on: 30/10/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.